Abbott And Teva Settle Fight Over Biaxin

Law360, New York (August 2, 2006, 12:00 AM EDT) -- Teva Pharmaceuticals USA and Abbott Laboratories have settled a patent infringement lawsuit over the marketing of a generic version of Abbott’s extended-release antibiotic Biaxin.

In documents filed Monday, the two companies asked the court to dismiss the case.

Terms of the settlement were not disclosed in court documents. Whether the settlement changes plans Teva had to sell a generic version of Biaxin remains unclear.

Jonathon Hamilton, a spokesperson for Abbott, said the terms were confidential and that he couldn’t say whether the settlement affects Teva’s sale...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.